Sign in Subscribe
Sensors

Abbott Introduces FreeStyle Libre 3 Plus Sensor in Canada, Revolutionizing Diabetes Care

Strategic Insights

— 2 min read

Abbott's FreeStyle Libre 3 Plus sensor, the world's smallest 1 glucose sensor, is now available to Canadians living with diabetes. This innovative product eliminates the need for routine finger pricks, empowering individuals to manage their condition more effectively. With over 7 million people worldwide using Libre technology, Abbott continues to pioneer ground-breaking technology to support people living with diabetes.

Key Takeaways:

  • The FreeStyle Libre 3 Plus sensor is the world's smallest 1 glucose sensor, measuring glucose levels in interstitial fluid through a small sensor worn on the back of the upper arm.
  • Sensor-based glucose monitoring plays a crucial role in diabetes management, allowing individuals to track glucose levels in real-time and make informed decisions about their care.
  • Nearly 12 million Canadians are living with type 1 or type 2 diabetes, with around 90% or more having type 2 5.
  • The Libre system shows people living with diabetes how different foods and exercise can impact their glucose levels over time, helping them make more informed decisions on how they can manage their diabetes on their own terms.
  • The FreeStyle Libre 3 Plus sensor is user-friendly and compact, offering transformative benefits to people living with diabetes, enabling them to manage their health with confidence.
  • Abbott has led the way in advancing the standard of care for millions of people living with diabetes worldwide, with a portfolio of life-changing technologies that spans the spectrum of healthcare.
  • There is full or partial reimbursement for Libre systems in more than 40 countries 2, making it accessible to a wider audience.

Statistics:

  • Nearly 12 million Canadians are living with type 1 or type 2 diabetes, with around 90% or more having type 2 5.
  • Over 7 million people worldwide use Libre technology, providing insights into how food, activity, or insulin impacts their glucose levels.
  • 1 The FreeStyle Libre 3 Flash Glucose Monitoring System is indicated for measuring interstitial fluid glucose levels continuously in people aged 2 years and older with diabetes mellitus.
  • 2 There is full or partial reimbursement for Libre systems in more than 40 countries, making it accessible to a wider audience.
  • 114,000 Abbott colleagues serve people in more than 160 countries, demonstrating the company's commitment to global healthcare leadership.

Sources:

  • https://www.niddk.nih.gov/health-information/diabetes/overview/managing-diabetes/continuous-glucose-monitoring (National Institute of Diabetes and Digestive and Kidney Diseases)
  • "Diabetes in Canada -- Estimate Prevalence and Cost of Diabetes" (Diabetes Canada)
  • Data on file, Abbott Diabetes Care (based on the number of patients assigned to each manufacturer)
  • Fokkert, M. BMJ Open Diabetes Research & Care (2019)
  • https://doi-org.sdpl.idm.oclc.org/10.1136/bmjdrc-2019-000809 (BMJ Open Diabetes Research & Care)

Read more